Nila Spaces Ltd
₹9.82
-0.20 (2.00%)
Fri, 06 Nov 2026, 09:26 pm
Nila Spaces News
Nila Spaces Q2FY27: Profit dips, revenue falls
Nila Spaces Limited reported a 9% YoY decline in standalone net profit for Q2FY27. Revenue from operations fell 30% YoY to ₹2,961 lakh.
30 Oct 2026
companies
Nila Spaces AGM approves Deep Vadodaria as CMD
Nila Spaces Ltd held its 26th AGM on September 29, 2026. Shareholders approved the appointment of Deep S. Vadodaria as Chairman & Managing Director and adopted FY26 financial statements.
29 Sept 2026
companies
Nila Spaces promoter sells shares
Promoter Kiran B Vadodaria sold 10,00,000 shares, reducing stake to 6.36% via open market transactions on September 17 and 18, 2026.
22 Sept 2026
companies
Nila Spaces seeks approval for key resolutions
Nila Spaces Limited has called for a postal ballot ending August 5, 2026, to approve the appointment of its CMD and Finance Director, and to enhance borrowing and investment limits up to ₹750 crore.
06 Jul 2026
companies
Nila Spaces opens share transfer window
Nila Spaces Limited has opened a special window for shareholders to re-lodge physical share transfer requests until February 4, 2027.
24 Jun 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo